|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00441181 |
|
Date of registration:
|
27/02/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Effects of Travoprost on Neovascular Glaucoma
|
|
Scientific title:
|
Effects of Travoprost on Neovascular Glaucoma |
|
Date of first enrolment:
|
January 2008 |
|
Target sample size:
|
40 |
|
Recruitment status: |
Withdrawn |
|
URL:
|
http://clinicaltrials.gov/show/NCT00441181 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Brazil
| | | | | | | |
|
Contacts
|
|
Name:
|
Luiz A Melo Jr, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Federal University of São Paulo |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Neovascular glaucoma of known cause
- Older than 18 years
- Previously submitted to retinal photocoagulation
- Under medical treatment to glaucoma
Exclusion Criteria:
- Need of antiglaucomatous surgery
- Previous ocular surgery in the last 6 months
- Pregnancy
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Neovascular Glaucoma
|
|
Intervention(s)
|
|
Drug: Travoprost
|
|
Primary Outcome(s)
|
|
Intraocular pressure
|
|
Secondary Outcome(s)
|
|
Inflammation
|
|
Secondary ID(s)
|
|
UNIFESP 2007-02
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|